Significant Insider Selling Continues at Cantel Medical (CMD)

Wednesday, January 17, 2018 10:15 PM ET

Significant Insider Selling Continues at Cantel Medical (CMD)

A SEC filing today revealed a notable insider sale of Cantel Medical shares as — Charles M Diker, 10% Owner, Director and Officer — disposed of 10,000 shares in the company having a market value of approximately $1,109,564. There have been 4 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the disposition of 31,546 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 41,546 shares and have averaged 8,309 shares per transaction over this time period.

Over the last 90 days, the number of insider buy/sell trades at Cantel Medical is greater than the 8-company peer group average. Medical Equipment Wholesale peer group saw 2 buy/sell trades during this period for an average of 0.3 transactions per company. The number of shares per buy/sell trade for Cantel Medical insiders was also higher. Within the peer group there were 2,834 shares purchased and 750 shares sold with company insiders purchasing 1,042 shares on average.

To bring into focus significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated in data used to compose and write this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.